| Financial Year |
March 31 2023 |
| Monetary Funds |
44,272,302.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,689,363.34 |
| Accounts Receivable |
60,577,715.50 |
| Advances to Suppliers |
8,015,033.62 |
| Other Receivables |
1,988,621.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,407,411.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,087,011.31 |
| Total Current Assets |
211,287,458.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
49,802,393.40 |
| Investment Properties |
-- |
| Fixed Assetes |
172,100,569.67 |
| Under-construction Projects |
43,015,527.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,414,709.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
32,474.17 |
| Deferred Income Tax Assets |
5,224,008.16 |
| Other Non-Current Assets |
1,289,358.36 |
| Sub-Total of Non-Current Assets |
312,686,490.19 |
| Total Assets |
523,973,948.91 |
| Short-Term Loans |
19,287,514.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
32,217,549.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,707,306.09 |
| Taxes Payable |
2,035,778.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,483,454.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,904,069.00 |
| Other Current Liabilities |
94,665.49 |
| Sub-Total of Current Liabilities |
63,679,384.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,245.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,065,202.51 |
| Total Liabilities |
68,744,587.20 |
| Paid-In Capital(Or Share Stock) |
130,673,200.00 |
| Capital Surplus |
75,673,493.75 |
| Surplus Reserve |
24,035,230.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
207,202,065.71 |
| Minority Stockholder's Interest |
17,648,835.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
437,580,526.58 |
| Owner's Equity（Stockholder's Equity） |
455,229,361.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
523,973,948.91 |
